Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 8

1.
2.

Transjugular intrahepatic portosystemic shunt complications: prevention and management.

Suhocki PV, Lungren MP, Kapoor B, Kim CY.

Semin Intervent Radiol. 2015 Jun;32(2):123-32. doi: 10.1055/s-0035-1549376. Review.

PMID:
26038620
3.

Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis.

Zhao JB, Feng C, Zhu QH, He XF, Li YH, Chen Y.

World J Gastroenterol. 2014 Feb 14;20(6):1602-7. doi: 10.3748/wjg.v20.i6.1602.

4.

Comparison of modified percutaneous transhepatic variceal embolization and endoscopic cyanoacrylate injection for gastric variceal rebleeding.

Wang J, Tian XG, Li Y, Zhang CQ, Liu FL, Cui Y, Liu JY.

World J Gastroenterol. 2013 Feb 7;19(5):706-14. doi: 10.3748/wjg.v19.i5.706.

5.

Transjugular intrahepatic portosystemic shunt using the FLUENCY expanded polytetrafluoroethylene-covered stent.

Wu Q, Jiang J, He Y, Jiang T, Zhou S.

Exp Ther Med. 2013 Jan;5(1):263-266. Epub 2012 Oct 30.

6.

Bacteremia and "Endotipsitis" following transjugular intrahepatic portosystemic shunting.

Mizrahi M, Roemi L, Shouval D, Adar T, Korem M, Moses A, Bloom A, Shibolet O.

World J Hepatol. 2011 May 27;3(5):130-6. doi: 10.4254/wjh.v3.i5.130.

7.

Rebleeding rates following TIPS for variceal hemorrhage in the Viatorr era: TIPS alone versus TIPS with variceal embolization.

Gaba RC, Bui JT, Cotler SJ, Kallwitz ER, Mengin OT, Martinez BK, Berkes JL, Carrillo TC, Knuttinen MG, Owens CA.

Hepatol Int. 2010 Aug 6;4(4):749-56. doi: 10.1007/s12072-010-9206-2.

8.

Recurrent thrombotic occlusion of a transjugular intrahepatic portosystemic stent-shunt due to activated protein C resistance.

Siewert E, Salzmann J, Purucker E, Schürmann K, Matern S.

World J Gastroenterol. 2005 Aug 28;11(32):5064-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk